key: cord-0995050-1bc6vsp1
authors: Ahnach, Maryame
title: Peripheral Blood Smears in COVID-19: A Response
date: 2021-02-25
journal: Turk J Haematol
DOI: 10.4274/tjh.galenos.2020.2020.0723
sha: 02bcc791c482e4fd42147b83651f440c2e327d4b
doc_id: 995050
cord_uid: 1bc6vsp1

nan

In our experience of patients with COVID-19 admitted to the Cheikh Khalifa International University Hospital, we found 30.3% of severe cases with a 57.9% comorbidity rate and 23.3% rate of other diseases, but no cases of parasitic infection or allergic manifestations during hospital admission [1] . Consistent with the current evidence, asthma and allergic comorbidities do not seem to increase the risk for poor outcomes in cases of COVID-19 [2] . However, many publications report the diagnostic and prognostic value of eosinopenia in COVID-19 infection [3, 4] . The pathophysiology for eosinopenia may be multifactorial, including inhibition of eosinophil egress from the bone marrow, blockade of eosinophilopoiesis, reduced expression of chemokine receptors/adhesion factors, and/or direct eosinophil apoptosis induced by type 1 interferons released during the acute infection [2] . The role of eosinophils remains unclear, but this does not exclude their impact on blood cell morphology. Regarding neutrophil lineages, Zini et al. [5] made a similar observation about dysmorphic granulocytes.

COVID-19 causes inflammatory and thrombotic complications, which can lead to both quantitative and qualitative hematologic abnormalities. Studies remain limited and we need a large number of cases to analyze the changes in blood cell morphology during COVID-19.

Anahtar Sözcükler: Kan hücreleri, COVID-19, Bulaşıcı hastalıklar Ethics Ethics Committee Approval: Our study was supported with the approval of the Academic Ethics Committee of Mohammed VI University.

Informed Consent: Informed consent was obtained from the patients included in the study.

The authors declared that this study received no financial support.

C-reactive protein as an early predictor of COVID-19 severity

Eosinophil response during COVID-19 infections and coronavirus vaccination

The role of peripheral blood eosinophil counts in COVID-19 patients

Eosinopenia is associated with greater severity in patients with coronavirus disease 2019

Morphological anomalies of circulating blood cells in COVID-19